Pacemaker Implantation Following Transcatheter Tricuspid Valve Replacement
Recruiting
Observational Study
AV Block Complete
Tricuspid Regurgitation (TR)
No Study Drug
Researchers observe your health over time — no experimental treatment is given.
At a Glance
- Sex
- Any
- Study type
- Observational
- Participants needed
- 25 (estimated)
- Sponsor
- Deutsches Herzzentrum Muenchen · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
Transcatheter tricuspid valve replacement (TTVR) is associated with a high risk of third-degree atrioventricular block (AVB). However, the optimal pacemaker management following TTVR remains unclear. This study aims to identify an optimal therapeutic approach for pacemaker implantation in patients undergoing TTVR.
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Transcatheter Tricuspid Valve Replacement
Exclusion Criteria:
* no defined exclusion criteria
Contacts